Cargando…

Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients

BACKGROUND: The empirical basis for a quantitative assessment of the disease burden imposed by long-COVID is currently scant. We aimed to inform the disease burden caused by long-COVID in Japan. METHODS: We conducted a cross sectional self-report questionnaire survey. The questionnaire was mailed to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsuzuki, Shinya, Miyazato, Yusuke, Terada, Mari, Morioka, Shinichiro, Ohmagari, Norio, Beutels, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388960/ https://www.ncbi.nlm.nih.gov/pubmed/35986269 http://dx.doi.org/10.1186/s12955-022-02033-6

Ejemplares similares

Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019
por: Miyazato, Yusuke, et al.
Publicado: (2020)

2259. Reversal of antimicrobial consumption: long-term impact of COVID-19 pandemic
por: Koizumi, Ryuji, et al.
Publicado: (2023)

Social contact patterns in Japan in the COVID-19 pandemic during and after the Tokyo Olympic Games
por: Tsuzuki, Shinya, et al.
Publicado: (2022)

Factors associated with development and persistence of post-COVID conditions: A cross-sectional study()
por: Miyazato, Yusuke, et al.
Publicado: (2022)

Predictors of silent hypoxia in hospitalized patients with COVID-19 in Japan
por: Hayakawa, Kayoko, et al.
Publicado: (2022)

Considerations and concerns regarding the readiness to remove face coverings
por: Terada, Mari, et al.
Publicado: (2022)

First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics
por: Saito, Sho, et al.
Publicado: (2021)

Impact of regional heterogeneity on the severity of COVID-19
por: Tsuzuki, Shinya, et al.
Publicado: (2022)

Preserved SARS-CoV-2 neutralizing IgG activity of in-house manufactured COVID-19 convalescent plasma
por: Inada, Makoto, et al.
Publicado: (2023)

Regional trends in the use of steroids and favipiravir for COVID-19 treatment
por: Asai, Yusuke, et al.
Publicado: (2023)

1147. Regional Trends in Favipiravir and Steroid Use in the Treatment of COVID-19
por: Asai, Yusuke, et al.
Publicado: (2022)

Effect of evacuation of Japanese residents from Wuhan, China, on preventing transmission of novel coronavirus infection: A modelling study
por: Asai, Yusuke, et al.
Publicado: (2021)

The estimated disease burden of COVID-19 in Japan from 2020 to 2021
por: Tsuzuki, Shinya, et al.
Publicado: (2023)

Effect of temperature on the infectivity of COVID-19
por: Ujiie, Mugen, et al.
Publicado: (2020)

We Should Pay More Attention to Sex Differences to Predict the Risk of Severe COVID-19: Men Have the Same Risk of Worse Prognosis as Women More Than 10 Years Older
por: Matsushita, Yumi, et al.
Publicado: (2023)

Acute portal vein thrombosis with COVID-19 and cirrhosis
por: Miyazato, Yusuke, et al.
Publicado: (2021)

Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan
por: Terada, Mari, et al.
Publicado: (2021)

Characteristics of hospitalized COVID-19 patients with other respiratory pathogens identified by rapid diagnostic test
por: Suzuki, Michiyo, et al.
Publicado: (2023)

223. Difference in Carbapenem Use by ASP Intervention in Japanese Healthcare Facilities
por: Endo, Mio, et al.
Publicado: (2020)

Risk factors associated with asymptomatic hypoxemia among COVID-19 patients: a retrospective study using the nationwide Japanese registry, COVIREGI-JP
por: Akiyama, Yutaro, et al.
Publicado: (2022)

Comparison of the clinical characteristics and outcomes of Japanese patients with COVID-19 treated in primary, secondary, and tertiary care facilities
por: Tomidokoro, Daiki, et al.
Publicado: (2023)

Beau's Lines and Leukonychia in a COVID-19 Patient
por: Ide, Satoshi, et al.
Publicado: (2020)

A nationwide prospective cohort study on safety of the 17D-204 yellow fever vaccine during a vaccine shortage in Japan
por: Miyazato, Yusuke, et al.
Publicado: (2022)

Renin-angiotensin system blocker and the COVID-19 aggravation in patients with hypertension, diabetes, renal failure, Cerebro-cardiovascular disease, or pulmonary disease: Report by the COVID-19 Registry Japan
por: Yoshihara, Fumiki, et al.
Publicado: (2022)

External validation and update of prediction models for unfavorable outcomes in hospitalized patients with COVID-19 in Japan
por: Yamada, Gen, et al.
Publicado: (2021)

Predicting respiratory failure for COVID-19 patients in Japan: a simple clinical score for evaluating the need for hospitalisation
por: Yamada, Gen, et al.
Publicado: (2021)

Successful use of casirivimab/imdevimab anti-spike monoclonal antibodies to enhance neutralizing antibodies in a woman on anti-CD20 treatment with refractory COVID-19
por: Miyazato, Yusuke, et al.
Publicado: (2022)

Antimicrobial Use Fell Substantially in Japan in 2020—The COVID-19 Pandemic May Have Played a Role
por: Ono, Akane, et al.
Publicado: (2022)

Recovery of quality of life after laparoscopic myomectomy
por: Tsuzuki, Yoko, et al.
Publicado: (2018)

Protocol of Tecopox study: a multicentre, open-label, double-arm trial to evaluate the efficacy and safety of oral tecovirimat therapy for patients with smallpox or monkeypox
por: Suzuki, Tetsuya, et al.
Publicado: (2023)

Exacerbations of Idiopathic Systemic Capillary Leak Syndrome following BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech)
por: Akiyama, Yutaro, et al.
Publicado: (2023)

Predictive model of risk factors of High Flow Nasal Cannula using machine learning in COVID-19
por: Matsunaga, Nobuaki, et al.
Publicado: (2022)

Factors associated with sufficient knowledge of antibiotics and antimicrobial resistance in the Japanese general population
por: Tsuzuki, Shinya, et al.
Publicado: (2020)

1295. Cross-sectional survey on education of clinical infectious diseases and antimicrobial resistance in pharmaceutical department in Japanese universities
por: Koizumi, Ryuji, et al.
Publicado: (2022)

Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection
por: Inada, Makoto, et al.
Publicado: (2022)

Clinical characteristics of COVID-19 in hospitalized children during the Omicron variant predominant period
por: Shoji, Kensuke, et al.
Publicado: (2022)

Comparison of the clinical characteristics and outcomes of COVID-19 in children before and after the emergence of Delta variant of concern in Japan
por: Shoji, Kensuke, et al.
Publicado: (2022)

Clinical Epidemiology of Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan: Report of the COVID-19 Registry Japan
por: Matsunaga, Nobuaki, et al.
Publicado: (2020)

Temporal trends in microbial detection during the COVID-19 pandemic: Analysis of the Japan surveillance for Infection Prevention and Healthcare Epidemiology (J-SIPHE) database
por: Endo, Akira, et al.
Publicado: (2023)

Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19
por: Kutsuna, Satoshi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_da2g9l9r6jnofdm3p9nk43as1v